`Case 1:17-cv-01407-CFC Document 387 Filed 05/30/19 Page 1 of 2 PagelD #: 34459
`
`IN THE UNITED STATES DISTRICT COURT
`FOR THE DISTRICT OF DELAWARE
`
`C. A. No.: 17-1407-CFC
`CONSOLIDATED
`
`) )
`
`)
`)
`
`) )
`
`) )
`
`GENENTECH, INC. and CITY OF HOPE
`
`Plaintiffs,
`
`V.
`
`AMGEN INC.
`
`Defendant.
`
`l.,
`AND NOW, this)?!“day of ”a , 2019, having considered Amgen’s Inc.’s
`
`
`
`ORDER
`
`March 8, 2019 discovery disptite letter in CA. No. 18—924 seeking to compel the production of
`
`certain licensing and settlement agreements and related documents (D.I. 290) and Amgen’s
`
`renewed letter dated May 13, 2019 seeking to compel the same production (together the “Motion
`
`to Compel”), and the responses thereto, and having held a discovery conference on May 16, 2019
`
`regarding the same;
`
`IT IS HEREBY ORDERED that Amgen’s Motion to Compel is GRANTED-IN-PART
`
`AND DENIED-IN-PART WITHOUT PREJUDICE. Genentech, Inc. (“Genentech”) shall
`
`produce licensing and/or settlement agreements resolving the following actions:
`
`a. Genentech, Inc, et al. v. Pfizer, Inc, CA. No. 17-1672-CFC (D. Del);
`
`b. Genentech, Inc, et al. v. Celltrion, Inc. et al., CA. No. 18-0095-CFC (D. Del.);
`
`0. Genentech, Inc, et al. v. Celltrion, Inc. et 521., CA. No. 18-1025-CFC (D. Del.)
`
`d. Mylan Pharmaceuticals Inc. v. Genentech, Inc., IPR 2016-01693; and
`
`e. Mylan Pharmaceuticals Inc. v. Genentech, Inc, IPR 2016-01694.
`
`MEI 30507805v.l
`
`
`
`Case 1:17-cv-01407-CFC Document 387 Filed 05/30/19 Page 2 of 2 PageID #: 34460
`Case 1:17-cv-01407-CFC Document 387 Filed 05/30/19 Page 2 of 2 PageID #: 34460
`
`While Genentech may redact the agreed-upon launch dates and confidential terms that are not
`
`relevant to the consideration for the licenses, Genentech may not redact any other terms of the
`
`licensing and/or settlement agreements that have any relevance to the value placed upon any of
`
`the patents implicated therein, including but not limited to royalties, lump sum payments, or any
`
`other consideration identified in the agreements. See Hearing Tr. (May 16, 2019) at 67-77.
`
`day ofMay, 2019.
`
`
`
`
`ates Distric
`
`u ge
`
`
`
`
`
`United
`
`IT IS so ORDERED this 3 77"
`
`MEI 30507805V.l
`
`